Gabapentin: The Pioneer of Neuropathic Relief

Gabapentin, synthesized in the 1970s and marketed globally as Neurontin, was the first “gabapentinoid” to reach the Indian market. Originally designed to treat epilepsy, clinicians quickly discovered its remarkable ability to quiet the “fire” of nerve pain—particularly the agonizing burning sensation that follows a Shingles infection (Post-Herpetic Neuralgia). While its successor, Pregabalin, is more potent and rapidly absorbed, Gabapentin remains a foundational medication in Indian neurology clinics due to its unique “self-limiting” absorption profile. However, as of April 2026, it has joined Pregabalin under the strict Schedule H1 regulations to combat a growing wave of pharmaceutical misuse.

This twenty-second installment provides an exhaustive analysis of Gabapentin in the Indian context for 2026.

---

1. Substance Profile & Classification

• Generic Name: Gabapentin
• Chemical Class: Gabapentinoid
• Therapeutic Class: Anticonvulsant / Neuropathic Pain Agent
• Indian Legal Status:
  • Schedule H1 Drug (April 2026 Update): In a coordinated move with other habit-forming pain medications, the Drugs Consultative Committee (DCC) shifted Gabapentin to Schedule H1 in April 2026. This requires pharmacies to maintain strict records of every sale, including patient identification and prescriber details.
  • Regulatory Focus: The shift aims to stop the “over-the-counter” diversion of Gabapentin, which had become a common substitute for opioids in several Northern and North-Eastern Indian states.

---

2. Market Availability and Pricing in India (May 2026)

Gabapentin is available in India in strengths of 100mg, 300mg, 400mg, and 600mg, often in combination with Methylcobalamin (Vitamin B12).

A. PMBJP (Jan Aushadhi Kendra) Availability

The Jan Aushadhi initiative provides Gabapentin at a fraction of the cost of commercial brands, making it accessible for elderly patients with chronic pain.

Medicine Name	Unit Size	Jan Aushadhi Price (INR)
Gabapentin Tablets IP 100 mg	10’s	₹14.44
Gabapentin Capsules IP 300 mg	10’s	₹25.79
Gabapentin (300mg) + Methylcobalamin (500mcg)	10’s	₹37.50
Gabapentin (400mg) + Nortriptyline (10mg)	10’s	₹51.57

B. Branded Market Prices (Commercial Sector)

Branded Gabapentin remains a premium product. As of 2026, most brands have updated their labels to reflect the Schedule H1 re-classification.

Brand Name	Manufacturer	Strength	Approx. Market Price (INR)
Gabapin	Intas Pharmaceuticals	300mg (15 Caps)	₹345.00
Pentanerv	Alkem Laboratories	300mg (10 Tabs)	₹198.00
Gabaneuron	Sun Pharma	300mg (10 Caps)	₹185.00
Gabator	Torrent Pharmaceuticals	100mg (10 Tabs)	₹82.00
Neurontin	Viatris (Legacy Pfizer)	300mg (10 Caps)	₹610.00
Gabantin	Sun Pharma	600mg (10 Tabs)	₹445.00

[!WARNING] Schedule H1 Register: Gabapentin is now under Schedule H1. Every purchase is recorded in a special register with your Aadhaar or ID details. Pharmacies selling without this audit trail face immediate license cancellation in 2026.

---

3. Clinical Pharmacology: The Saturable Secret

Mechanism of Action

Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels.

• The L-Amino Acid Transporter: Unlike most drugs, Gabapentin requires a specific “transport protein” in the gut to enter the bloodstream.
• Saturable Absorption (Non-Linearity): This transporter can only handle a certain amount of Gabapentin at a time. If you take 300mg, nearly 60% is absorbed. If you take 1200mg at once, the absorption rate drops to less than 35%.
• Clinical Significance: This makes Gabapentin inherently safer in large doses than Pregabalin, as the body literally “stops” absorbing it after a certain point.

Pharmacokinetics

• Bioavailability: Decreases as the dose increases.
• Half-life: Approximately 5 to 7 hours.
• Clearance: 100% renal (kidneys). It does not interact with the liver, making it safe for patients with liver cirrhosis but high-risk for those with kidney disease.

---

4. Clinical Context: Post-Herpetic Neuralgia (PHN)

Gabapentin is the “Gold Standard” in India for treating the pain of Shingles (Herpes Zoster).

• The Burning Pain: PHN causes a constant, sharp, or burning pain that can last for years after the skin rash has healed.
• The Titration Rule: Indian protocols usually start patients on a low dose (100mg-300mg at night) and slowly increase it every 3 days. Jumping directly to high doses causes extreme dizziness and “brain fog.”

---

5. Euphoria and Misuse: “The Gabbies”

Euphoria Profile

• The “Relaxed Blur”: Misusers take very high doses (often 1200mg-2400mg) to achieve a state of physical relaxation, mild euphoria, and a “talkative” social state.
• Dissociation: At high doses, users report feeling “lighter” or “walking on clouds,” similar to a mild dissociative state.

Misuse Trends in India 2026

1. Prison/Restricted Environments: Because it was historically less controlled than Alprazolam, Gabapentin became a currency in restricted environments across India.
2. Alcohol Cravings: Some individuals use Gabapentin to self-treat alcohol addiction, but this often results in a “cross-addiction” where the user cannot sleep or function without the drug.
3. The “High Dose” Hack: Because of its saturable absorption, experienced misusers often “stagger” their doses—taking 300mg every 30 minutes with a fatty meal—to bypass the gut’s transporter limits and achieve a stronger high.

---

6. Critical Risks: The “Brain Fog” and Fall Risk

• Cognitive Impact: Long-term high-dose use in India has been linked to significant “Brain Fog”—difficulty concentrating, word-finding problems, and extreme lethargy.
• Elderly Hazards: For patients over 65, Gabapentin is a major cause of nighttime falls and hip fractures due to its impact on balance and coordination (Ataxia).

---

7. Toxicity and Overdose

Overdose Signs

• Nystagmus (Involuntary eye movements).
• Severe Slurred Speech.
• Lethargy and Coma.
• Diarrhea (Due to the unabsorbed drug in the gut).

Emergency Action: Call 14446. There is no antidote. In severe cases of overdose in patients with poor kidney function, Hemodialysis (blood filtration) may be required to remove the drug from the system.

---

8. Legal Status and 2026 Regulatory Environment

• Schedule H1 Register: In 2026, pharmacies are required to maintain a “separate and distinct” register for Gabapentin. Inspectors now check if the quantity of Gabapin sold matches the prescriptions on file.
• Online Sales Ban: Most Indian e-pharmacies have restricted the shipping of Gabapentin to only those states where a digital H1-compliant verification system is in place.

---

9. Addiction and Withdrawal

Gabapentin dependence is physical. Stopping “Cold Turkey” is dangerous.

• Withdrawal Symptoms: Severe anxiety, insomnia, nausea, sweating, and heart palpitations.
• The Seizure Risk: Individuals taking Gabapentin for epilepsy face a high risk of Status Epilepticus if they skip doses.
• Recovery: Participation in a medically supervised taper is essential.

Resources for Help in India

• National Drug De-addiction Helpline: 14446
• VIMHANS: Delhi.
• Christian Medical College (CMC): Vellore (Specialized neurology-psychiatry integration).

---

10. Harm Reduction Strategies

• Divide Your Doses: For maximum pain relief, take Gabapentin in three divided doses (e.g., morning, afternoon, night) rather than one large dose.
• Kidney Check: Before starting Gabapentin, ensure your doctor has checked your Serum Creatinine levels. If your kidneys are weak, the drug will build up to toxic levels.
• The “Antacid” Rule: Do not take antacids (like Digene or Gelusil) within 2 hours of taking Gabapentin. Antacids can reduce the absorption of the drug by up to 20%.

---

Next in the Series: Part 23: Carisoprodol – The Muscle Relaxant with a Sedative Secret

Disclaimer: This series is for educational and harm-reduction purposes only. Gabapentin is a potent neurological medication. Never self-medicate or stop treatment abruptly without consulting your physician.